Source: BioPortfolio

Liverpool Chirochem: Cresset and Liverpool ChiroChem announce collaboration to curate cost effective novel and highly diverse compound libraries

Cresset provider of software and contract research services for small molecule drug discovery and Liverpool ChiroChem LCC a chemical technology innovator that produces chiral small molecules for biotech and pharmaceutical R&D announce a collaborati...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Paul Colbon's photo - Co-Founder & CEO of LCC

Co-Founder & CEO

Paul Colbon

CEO Approval Rating

87/100

Read more